Align Technology (ALGN) Set to Announce Quarterly Earnings on Wednesday

Align Technology (NASDAQ:ALGN) is projected to post its Q3 2026 results after the market closes on Wednesday, October 28th. Analysts expect Align Technology to announce earnings of $2.77 per share and revenue of $1.00 billion for the quarter. Investors can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Wednesday, October 28, 2026 at 4:30 PM ET.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 earnings per share for the quarter, beating analysts’ consensus estimates of $2.62 by $0.02. Align Technology had a net margin of 9.99% and a return on equity of 15.86%. The firm had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the previous year, the firm posted $2.49 earnings per share. The business’s revenue was up 4.3% on a year-over-year basis. On average, analysts expect Align Technology to post $9.27 EPS for the current fiscal year and $10.34 EPS for the next fiscal year.

Align Technology Stock Down 1.5%

Shares of ALGN stock opened at $152.26 on Tuesday. Align Technology has a 12-month low of $130.23 and a 12-month high of $200.43. The firm has a fifty day moving average of $152.07 and a 200-day moving average of $169.20. The company has a market capitalization of $10.90 billion, a price-to-earnings ratio of 17.11, a P/E/G ratio of 1.66 and a beta of 1.67.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Weiss Ratings raised shares of Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. Zacks Research cut Align Technology from a “hold” rating to a “strong sell” rating in a report on Thursday, October 15th. Piper Sandler dropped their price target on Align Technology from $235.00 to $205.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 21st. Leerink Partners dropped their price target on Align Technology from $235.00 to $215.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 14th. Finally, BMO Capital Markets started coverage on Align Technology in a research report on Wednesday, July 8th. They set an “outperform” rating and a $209.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $190.93.

About Align Technology

Align Technology, Inc is a global medical device company focused on digital orthodontics and restorative dentistry. Founded in 1997, the company is best known for the Invisalign system, a series of clear, removable aligners designed to gradually move teeth and treat a range of orthodontic conditions.

Align’s products and services also include digital scanning and dental practice solutions. Its iTero intraoral scanners create digital impressions for orthodontic and restorative procedures, while its exocad business develops computer-aided design and computer-aided manufacturing software used by dental laboratories, clinicians and other dental professionals.

The company serves orthodontists, dentists, dental laboratories and patients in numerous markets worldwide.